|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 47/68 | (2017.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 3628686 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19208570.2 |
| Date of filing the European patent application | 2009-06-25 | |
| (97) | Date of publication of the European application | 2020-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 75697 P | 2008-06-25 | US | |
| 7569208 P | 2008-06-25 | US | |
| 155041 P | 2009-02-24 | US | |
| 15510509 P | 2009-02-24 | US | |
| 8322009 | 2009-06-02 | CH |
| (72) |
BORRAS, Leonardo , CH
URECH, David , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK |
| HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK |